| REGN | Regeneron Pharmaceuticals Inc | $40.87B | +5377373.68% |
| VRTX | Vertex Pharmaceuticals Inc | $26.48B | +3484689.47% |
| BNTX | BioNTech SE | $21.10B | +2775699.71% |
| RPRX | Royalty Pharma plc - Class A | $19.82B | +2607191.45% |
| GMAB | Genmab | $12.38B | +1628294.71% |
| SVA | Sinovac Biotech Ltd | $12.34B | +1623226.45% |
| JAZZ | Jazz Pharmaceuticals plc | $11.86B | +1560373.68% |
| MRNA | Moderna Inc | $11.49B | +1511478.95% |
| ARGX | Argen X SE | $8.68B | +1142360.26% |
| BMRN | Biomarin Pharmaceutical Inc | $8.59B | +1130296.84% |
| ONC | BeiGene Ltd | $8.55B | +1125376.18% |
| INCY | Incyte Corp | $7.34B | +965572.76% |
| ROIV | Roivant Sciences Ltd | $5.71B | +751043.03% |
| ALNY | Alnylam Pharmaceuticals Inc | $4.97B | +653364.61% |
| AAPG | Ascentage Pharma Group International | $3.97B | +521755.39% |
| IONS | Ionis Pharmaceuticals Inc | $3.45B | +453843.29% |
| GLPG | Galapagos NV | $3.41B | +447935.29% |
| PCVX | Vaxcyte Inc | $3.35B | +440466.84% |
| SRPT | Sarepta Therapeutics Inc | $3.18B | +418180.79% |
| PTCT | PTC Therapeutics Inc | $2.87B | +377413.68% |
| CRSP | CRISPR Therapeutics AG | $2.73B | +358560.53% |
| FTRE | FORTE SOFTWARE INC | $2.68B | +352978.95% |
| HALO | Halozyme Therapeutics Inc | $2.67B | +351573.55% |
| NBP | NovaBridge Biosciences. | $2.61B | +343711.45% |
| EXEL | Exelixis Inc | $2.59B | +341162.24% |
| TECH | Bio-Techne Corp | $2.55B | +335505.39% |
| ENLV | Enlivex Therapeutics Ltd | $2.33B | +306083.95% |
| ARWR | Arrowhead Pharmaceuticals Inc | $2.27B | +298355.92% |
| RVMD | Revolution Medicines Inc | $2.25B | +296444.34% |
| INSM | Insmed Inc | $2.08B | +273039.87% |
| ASND | Ascendis Pharma A/S | $2.01B | +263764.23% |
| INVA | Innoviva Inc | $1.84B | +241556.18% |
| TLX | Telix Pharmaceuticals Ltd | $1.77B | +232915.07% |
| KYMR | Kymera Therapeutics Inc | $1.67B | +219507.37% |
| ACAD | Acadia Pharmaceuticals Inc | $1.61B | +211114.47% |
| LEGN | Legend Biotech Corp | $1.60B | +209998.62% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $1.53B | +201492.76% |
| TGTX | TG Therapeutics Inc | $1.53B | +201062.76% |
| GPCR | Structure Therapeutics Inc | $1.51B | +198337.37% |
| PRAX | Praxis Precision Medicines Inc | $1.46B | +192031.84% |
| CRNX | Crinetics Pharmaceuticals Inc | $1.40B | +184284.61% |
| KRYS | Krystal Biotech Inc | $1.40B | +183711.45% |
| XENE | Xenon Pharmaceuticals Inc | $1.39B | +182375.00% |
| BBIO | BridgeBio Pharma Inc | $1.37B | +180292.24% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.34B | +176152.89% |
| NUVL | Nuvalent Inc - Class A | $1.33B | +175051.05% |
| ABCL | AbCellera Biologics Inc | $1.31B | +171888.42% |
| RARE | Ultragenyx Pharmaceutical Inc | $1.30B | +170426.32% |
| APGE | Apogee Therapeutics Inc | $1.29B | +170117.63% |
| CYTK | Cytokinetics Inc | $1.27B | +167462.89% |
| HRMY | Harmony Biosciences Holdings Inc | $1.27B | +167245.26% |
| DNLI | Denali Therapeutics Inc | $1.27B | +166481.97% |
| DNTH | Dianthus Therapeutics Inc | $1.25B | +163963.68% |
| MDGL | Madrigal Pharmaceuticals Inc | $1.23B | +161390.39% |
| AGIO | Agios Pharmaceuticals Inc | $1.18B | +155819.74% |
| CAI | Caris Life Sciences Inc - Class A | $1.16B | +152845.79% |
| CPRX | Catalyst Pharmaceuticals Inc | $1.15B | +150901.32% |
| CVAC | CureVac N.V. | $1.14B | +149718.29% |
| CGON | Cg Oncology Inc | $1.14B | +149276.58% |
| ZLAB | Zai Lab Ltd | $1.10B | +144075.92% |
| APLS | Apellis Pharmaceuticals Inc | $1.08B | +142338.42% |
| DYN | Dyne Therapeutics Inc | $1.08B | +141998.68% |
| IMCR | Immunocore Holdings plc | $1.07B | +140965.13% |
| NVAX | Novavax Inc | $1.04B | +137158.16% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $1.03B | +135830.92% |
| IDYA | Ideaya Biosciences Inc | $1.03B | +135472.11% |
| JANX | Janux Therapeutics Inc | $1.03B | +135192.76% |
| VIR | Vir Biotechnology Inc | $1.03B | +134845.39% |
| TERN | Terns Pharmaceuticals Inc | $1.03B | +134778.68% |
| AKRO | Akero Therapeutics Inc | $1.01B | +132212.76% |
| RCUS | Arcus Biosciences Inc | $997.00M | +131084.21% |
| IMVT | Immunovant Inc | $957.01M | +125822.89% |
| FOLD | Amicus Therapeutics Inc | $949.87M | +124882.89% |
| IOVA | Iovance Biotherapeutics Inc | $925.66M | +121698.03% |
| MRUS | Merus N.V | $904.20M | +118873.16% |
| COGT | Cogent Biosciences Inc | $903.01M | +118716.58% |
| MIRM | Mirum Pharmaceuticals Inc | $890.92M | +117125.79% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $849.19M | +111635.66% |
| CRMD | CorMedix Inc | $815.64M | +107220.66% |
| CORT | Corcept Therapeutics Inc | $814.88M | +107121.18% |
| VRDN | Viridian Therapeutics Inc | $789.02M | +103718.03% |
| MESO | Mesoblast Ltd | $784.68M | +103147.76% |
| BLTE | Belite Bio Inc | $780.56M | +102604.74% |
| QURE | uniQure N.V. | $778.71M | +102361.32% |
| SYRE | Spyre Therapeutics Inc | $763.95M | +100420.13% |
| NKTR | Nektar Therapeutics | $763.27M | +100330.39% |
| NTLA | Intellia Therapeutics Inc | $758.78M | +99739.34% |
| IRON | Disc Medicine Inc | $750.21M | +98612.24% |
| ZBIO | Zenas Biopharma Inc | $747.68M | +98279.21% |
| MNKD | Mannkind Corp | $744.40M | +97847.76% |
| XNCR | Xencor Inc | $736.85M | +96853.42% |
| GLUE | Monte Rosa Therapeutics Inc | $736.43M | +96798.42% |
| NAMS | NewAmsterdam Pharma Company NV | $732.64M | +96300.39% |
| OCUL | Ocular Therapeutix Inc | $732.53M | +96285.39% |
| AUPH | Aurinia Pharmaceuticals Inc | $724.00M | +95162.76% |
| AXSM | Axsome Therapeutics Inc | $713.61M | +93795.66% |
| RLAY | Relay Therapeutics Inc | $699.61M | +91954.34% |
| PTGX | Protagonist Therapeutics Inc | $697.46M | +91670.92% |
| ALMS | Alumis Inc | $671.59M | +88266.84% |
| ADMA | Adma Biologics Inc | $665.18M | +87424.21% |
| MLYS | Mineralys Therapeutics Inc | $652.86M | +85802.89% |
| KURA | Kura Oncology Inc | $652.55M | +85761.97% |
| SMMT | Summit Therapeutics Inc | $647.86M | +85144.21% |
| ARVN | Arvinas Inc | $647.50M | +85097.37% |
| IBRX | ImmunityBio Inc | $646.64M | +84983.82% |
| CNTA | Centessa Pharmaceuticals plc | $641.76M | +84342.50% |
| NRIX | Nurix Therapeutics Inc | $636.13M | +83601.32% |
| VERA | Vera Therapeutics Inc - Class A | $621.74M | +81707.76% |
| IMNM | Immunome Inc | $619.79M | +81451.58% |
| NUVB | Nuvation Bio Inc - Class A | $610.24M | +80194.87% |
| SLNO | Soleno Therapeutics Inc | $608.39M | +79951.05% |
| VKTX | Viking Therapeutics Inc | $608.24M | +79931.84% |
| ACLX | Arcellx Inc | $603.99M | +79372.37% |
| THAR | Tharimmune Inc | $584.65M | +76828.24% |
| WVE | Wave Life Sciences Ltd | $583.54M | +76682.11% |
| TARS | Tarsus Pharmaceuticals Inc | $581.13M | +76365.13% |
| VRNA | Verona Pharma Plc | $572.87M | +75277.76% |
| SEPN | Septerna Inc | $569.69M | +74858.95% |
| TVTX | Travere Therapeutics Inc | $555.19M | +72951.05% |
| BCAX | Bicara Therapeutics Inc | $553.60M | +72741.97% |
| PRTC | PureTech Health plc American Depositary Shares | $553.24M | +72695.00% |
| ABVX | Abivax | $547.14M | +71892.37% |
| IMTX | Immatics N.V | $543.83M | +71456.65% |
| GLTO | Galecto Inc | $535.44M | +70352.89% |
| SRRK | Scholar Rock Holding Corp | $535.25M | +70328.16% |
| GERN | Geron Corp | $534.12M | +70178.95% |
| OLMA | Olema Pharmaceuticals Inc | $530.64M | +69721.71% |
| AUTL | Autolus Therapeutics plc | $527.07M | +69250.66% |
| CDTX | Cidara Therapeutics Inc | $518.65M | +68143.42% |
| EWTX | Edgewise Therapeutics Inc | $518.52M | +68126.58% |
| FDMT | 4D Molecular Therapeutics Inc | $512.90M | +67387.50% |
| CLDX | Celldex Therapeutics Inc | $511.25M | +67170.26% |
| DAWN | Day One Biopharmaceuticals Inc | $507.83M | +66719.34% |
| VOR | Vor Biopharma Inc | $506.75M | +66577.11% |
| RIGL | Rigel Pharmaceuticals | $504.61M | +66295.79% |
| ARDX | Ardelyx Inc | $504.51M | +66282.50% |
| ORKA | ARCA biopharma Inc | $504.48M | +66278.95% |
| RAPP | Rapport Therapeutics Inc | $497.60M | +65373.29% |
| PHAR | Pharming Group N.V. | $489.37M | +64290.13% |
| VCEL | Vericel Corp | $485.63M | +63798.29% |
| ZYME | Zymeworks BC Inc | $478.21M | +62823.03% |
| SNDX | Syndax Pharmaceuticals Inc | $472.67M | +62093.16% |
| TBPH | Theravance Biopharma Inc | $472.31M | +62046.45% |
| BHVN | Biohaven Ltd | $466.41M | +61269.21% |
| ELVN | Enliven Therapeutics Inc | $464.85M | +61064.74% |
| RVNC | Revance Therapeutics Inc | $461.56M | +60632.11% |
| ERAS | Erasca Inc | $461.23M | +60588.68% |
| ARQT | Arcutis Biotherapeutics Inc | $460.00M | +60426.71% |
| MBX | MBX Biosciences Inc | $452.70M | +59465.92% |
| STOK | Stoke Therapeutics Inc | $443.28M | +58225.92% |
| RYTM | Rhythm Pharmaceuticals Inc | $442.32M | +58099.47% |
| ORIC | ORIC Pharmaceuticals Inc | $436.76M | +57368.68% |
| SLRN | Acelyrin Inc | $436.50M | +57334.74% |
| TNGX | Tango Therapeutics Inc | $435.79M | +57241.05% |
| VNDA | Vanda Pharmaceuticals Inc | $433.52M | +56942.76% |
| SLDB | Solid Biosciences Inc | $422.89M | +55543.82% |
| MAZE | Maze Therapeutics Inc | $419.71M | +55125.00% |
| MPLT | MapLight Therapeutics Inc | $418.79M | +55003.68% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $417.65M | +54853.42% |
| TYRA | Tyra Biosciences Inc | $412.04M | +54115.79% |
| CELC | Celcuity Inc | $410.16M | +53868.95% |
| CGEM | Cullinan Oncology Inc | $402.98M | +52924.21% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $401.29M | +52701.71% |
| MLTX | MoonLake Immunotherapeutics - Class A | $400.37M | +52580.79% |
| ALLO | Allogene Therapeutics Inc | $395.96M | +51999.74% |
| LBRX | LB Pharmaceuticals Inc | $393.48M | +51673.95% |
| SANA | Sana Biotechnology Inc | $373.59M | +49056.97% |
| VALN | Valneva SE | $372.40M | +48900.13% |
| NKTX | Nkarta Inc | $372.07M | +48856.97% |
| CTMX | CytomX Therapeutics Inc | $359.36M | +47183.95% |
| FBIO | Fortress Biotech Inc | $356.87M | +46857.11% |
| PROK | ProKidney Corp - Class A | $351.61M | +46164.21% |
| LYEL | Lyell Immunopharma Inc | $350.63M | +46035.00% |
| PRTA | Prothena Corporation plc | $349.89M | +45938.68% |
| AVBP | ArriVent BioPharma Inc | $349.30M | +45859.87% |
| FULC | Fulcrum Therapeutics Inc | $346.77M | +45527.63% |
| RGNX | Regenxbio Inc | $341.89M | +44886.05% |
| ENGN | enGene Holdings Inc | $337.11M | +44256.97% |
| TRDA | Entrada Therapeutics Inc | $335.52M | +44047.11% |
| REPL | Replimune Group Inc | $333.59M | +43793.42% |
| ANAB | AnaptysBio Inc | $329.68M | +43279.47% |
| KALV | KalVista Pharmaceuticals Inc | $328.92M | +43178.55% |
| CCCC | C4 Therapeutics Inc | $328.86M | +43171.18% |
| IPSC | Century Therapeutics Inc | $326.55M | +42867.50% |
| CAPR | Capricor Therapeutics Inc | $326.28M | +42832.04% |
| CBUS | Cibus Global Ltd. Class A | $324.20M | +42558.16% |
| EVMN | Evommune Inc | $322.45M | +42328.29% |
| JBIO | Jade Biosciences Inc | $319.43M | +41930.66% |
| UPB | Upstream Bio Inc | $318.05M | +41749.21% |
| ENTA | Enanta Pharmaceuticals Inc | $314.70M | +41308.42% |
| KROS | Keros Therapeutics Inc | $312.29M | +40991.18% |
| DRUG | Bright Minds Biosciences Inc | $312.15M | +40971.81% |
| MDXG | Mimedx Group Inc | $308.68M | +40515.26% |
| KOD | Kodiak Sciences Inc | $306.01M | +40163.95% |
| PHAT | Phathom Pharmaceuticals Inc | $305.12M | +40047.37% |
| SION | Sionna Therapeutics Inc | $305.04M | +40036.71% |
| TSHA | Taysha Gene Therapies Inc | $300.35M | +39419.87% |
| PRME | Prime Medicine Inc | $294.73M | +38680.26% |
| OABI | OmniAb Inc | $293.65M | +38538.16% |
| RNA | Atrium Therapeutics Inc | $292.36M | +38368.42% |
| ADCT | Adc Therapeutics SA | $291.50M | +38254.74% |
| CLLS | Cellectis | $289.19M | +37950.92% |
| RNAC | Cartesian Therapeutics Inc | $288.39M | +37846.18% |
| EYPT | EyePoint Pharmaceuticals Inc | $288.22M | +37823.29% |
| SPRY | ARS Pharmaceuticals Inc | $287.57M | +37738.29% |
| OMER | Omeros Corporation | $286.17M | +37554.34% |
| RCKT | Rocket Pharmaceuticals Inc | $285.41M | +37453.55% |
| FATE | Fate Therapeutics Inc | $284.92M | +37388.95% |
| ALT | Altimmune Inc | $279.93M | +36732.76% |
| THRD | Third Harmonic Bio Inc | $279.84M | +36720.53% |
| ZVRA | Zevra Therapeutics Inc | $278.58M | +36555.13% |
| ABUS | Arbutus Biopharma Corp | $277.16M | +36368.95% |
| ANRO | Alto Neuroscience Inc | $276.26M | +36249.87% |
| GHRS | GH Research PLC | $275.27M | +36119.34% |
| LENZ | LENZ Therapeutics Inc | $272.54M | +35759.87% |
| SEER | Seer Inc - Class A | $272.13M | +35706.84% |
| ATXS | Astria Therapeutics Inc | $271.87M | +35671.84% |
| XOMA | XOMA Corp | $271.86M | +35670.79% |
| XFOR | X4 Pharmaceuticals Inc | $270.28M | +35463.29% |
| TRML | Tourmaline Bio Inc | $269.30M | +35333.55% |
| ORMP | Oramed Pharmaceuticals Inc | $268.85M | +35274.61% |
| LXRX | Lexicon Pharmaceuticals Inc | $268.82M | +35270.92% |
| AVIR | Atea Pharmaceuticals Inc | $267.08M | +35041.58% |
| DBVT | DBV Technologies | $266.40M | +34952.63% |
| CHRS | Coherus Biosciences Inc | $266.02M | +34902.89% |
| ATAI | ATAI Life Sciences N.V. | $264.88M | +34752.24% |
| PVLA | Palvella Therapeutics Inc | $263.76M | +34605.13% |
| NGNE | Neoleukin Therapeutics Inc | $263.14M | +34523.82% |
| ANNX | Annexon Inc | $262.89M | +34490.53% |
| TCRX | Tscan Therapeutics Inc | $262.23M | +34403.29% |
| CTNM | Contineum Therapeutics Inc - Class A | $261.35M | +34288.03% |
| PHVS | Pharvaris NV | $260.06M | +34118.29% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $257.91M | +33835.79% |
| KYTX | Kyverna Therapeutics Inc | $257.02M | +33718.95% |
| URGN | UroGen Pharma Ltd | $253.69M | +33280.26% |
| CRVS | Corvus Pharmaceuticals Inc | $253.19M | +33215.13% |
| ZNTL | Zentalis Pharmaceuticals Inc | $253.07M | +33198.16% |
| LXEO | Lexeo Therapeutics Inc | $250.36M | +32841.58% |
| SABS | SAB Biotherapeutics Inc | $248.47M | +32593.49% |
| TECX | AvroBio Inc | $246.58M | +32344.34% |
| HRTX | Heron Therapeutics Inc | $246.22M | +32296.84% |
| ARCT | Arcturus Therapeutics Holdings Inc | $245.41M | +32190.92% |
| MGTX | MeiraGTx Holdings plc | $244.66M | +32091.45% |
| OCS | Oculis Holding AG | $243.26M | +31908.45% |
| STRO | Sutro Biopharma Inc | $241.99M | +31740.53% |
| IVVD | Invivyd Inc | $241.74M | +31708.16% |
| ALEC | Alector Inc | $239.92M | +31467.89% |
| ASMB | Assembly Biosciences Inc | $235.51M | +30887.89% |
| RLMD | Relmada Therapeutics Inc | $235.36M | +30868.79% |
| DSGN | Design Therapeutics Inc | $230.44M | +30221.32% |
| ZURA | Zura Bio Ltd - Class A | $228.64M | +29984.34% |
| VSTM | Verastem Inc | $227.81M | +29874.74% |
| OVID | Ovid Therapeutics Inc | $225.63M | +29587.89% |
| FHTX | Foghorn Therapeutics Inc | $222.17M | +29132.50% |
| SVRA | Savara Inc | $221.65M | +29063.82% |
| VYGR | Voyager Therapeutics Inc | $219.32M | +28758.55% |
| MGNX | Macrogenics Inc | $217.87M | +28567.50% |
| IMRX | Immuneering Corp Class A | $214.81M | +28164.45% |
| VTYX | Ventyx Biosciences Inc | $211.47M | +27724.34% |
| LRMR | Larimar Therapeutics Inc | $208.51M | +27335.66% |
| IMAB | I-Mab | $206.71M | +27098.42% |
| SNSE | Sensei Biotherapeutics Inc | $205.38M | +26923.82% |
| CMPX | Compass Therapeutics Inc | $205.17M | +26896.05% |
| PLRX | Pliant Therapeutics Inc | $202.60M | +26557.37% |
| CADL | Candel Therapeutics Inc | $201.92M | +26468.42% |
| TIL | Instil Bio Inc | $200.43M | +26272.11% |
| CBIO | Crescent Biopharma Inc | $199.13M | +26101.32% |
| ACRS | Aclaris Therapeutics Inc | $198.72M | +26047.37% |
| ABEO | Abeona Therapeutics Inc | $198.49M | +26017.63% |
| MGX | Metagenomi Inc | $196.95M | +25814.87% |
| ABSI | Absci Corp | $195.59M | +25635.92% |
| MIST | Milestone Pharmaceuticals Inc | $193.73M | +25391.32% |
| PBYI | Puma Biotechnology Inc | $192.70M | +25255.13% |
| TARA | Protara Therapeutics Inc | $191.92M | +25153.03% |
| IMUX | Immunic Inc | $189.74M | +24866.05% |
| BNTC | Benitec Biopharma Inc | $187.00M | +24505.26% |
| AGEN | Agenus Inc | $186.46M | +24433.68% |
| INBX | Inhibrx Biosciences Inc | $183.97M | +24106.18% |
| KRRO | Korro Bio Inc | $183.62M | +24060.79% |
| VXRT | Vaxart Inc | $180.06M | +23591.45% |
| NBY | Stablecoin Development Corp | $179.74M | +23550.39% |
| TRVI | Trevi Therapeutics Inc | $179.61M | +23532.37% |
| IVA | Inventiva | $178.52M | +23389.21% |
| ALXO | Alx Oncology Holdings Inc | $178.33M | +23364.21% |
| NAUT | Nautilus Biotechnology Inc | $177.78M | +23291.97% |
| HLVX | HilleVax Inc | $174.91M | +22915.00% |
| IKT | Inhibikase Therapeutics Inc | $173.33M | +22706.87% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $172.19M | +22556.29% |
| AURA | Aura Biosciences Inc | $169.43M | +22193.42% |
| ACET | Adicet Bio Inc | $169.38M | +22187.11% |
| RAPT | RAPT Therapeutics Inc | $165.74M | +21707.76% |
| XLO | Xilio Therapeutics Inc | $163.49M | +21411.45% |
| GYRE | Gyre Therapeutics Inc | $162.01M | +21217.76% |
| RNAZ | TransCode Therapeutics Inc | $157.16M | +20579.59% |
| CGEN | Compugen Ltd | $156.57M | +20501.32% |
| PEPG | PepGen Inc | $156.29M | +20465.13% |
| NMRA | Neumora Therapeutics Inc | $153.88M | +20146.97% |
| CLYM | Eliem Therapeutics Inc | $152.37M | +19948.95% |
| EDIT | Editas Medicine Inc | $149.34M | +19549.74% |
| CRBU | Caribou Biosciences Inc | $149.00M | +19505.00% |
| CABA | Cabaletta Bio Inc | $148.15M | +19392.89% |
| IMMP | Immutep Ltd | $147.20M | +19268.67% |
| ELDN | Eledon Pharmaceuticals Inc | $146.67M | +19198.29% |
| CMRX | Chimerix Inc | $146.01M | +19111.58% |
| OPT | Opthea Ltd | $145.77M | +19080.26% |
| PTHS | Channel Therapeutics Corporation | $145.38M | +19028.68% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $144.48M | +18910.53% |
| DTIL | Precision Biosciences Inc | $143.89M | +18833.03% |
| BOLD | Boundless Bio Inc | $140.97M | +18448.68% |
| XBIT | XBiotech Inc | $139.84M | +18299.47% |
| PGEN | Precigen Inc | $138.63M | +18140.39% |
| MNPR | Monopar Therapeutics Inc | $137.98M | +18055.75% |
| ACIU | AC Immune SA | $137.42M | +17981.71% |
| IMA | Ikena Oncology Inc | $136.68M | +17884.47% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $135.37M | +17711.89% |
| TNYA | Tenaya Therapeutics Inc | $135.07M | +17672.37% |
| ABOS | Acumen Pharmaceuticals Inc | $133.63M | +17482.76% |
| PALI | Palisade Bio Inc | $133.31M | +17441.45% |
| AVXL | Anavex Life Sciences Corporation | $132.99M | +17398.55% |
| BDTX | Black Diamond Therapeutics Inc | $132.92M | +17389.74% |
| CTXR | Citius Pharmaceuticals Inc | $132.54M | +17339.55% |
| KPTI | Karyopharm Therapeutics Inc | $131.42M | +17191.71% |
| ARTV | Artiva Biotherapeutics Inc | $130.94M | +17128.95% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $130.63M | +17088.55% |
| CDXS | Codexis Inc | $129.37M | +16922.37% |
| GOSS | Gossamer Bio Inc | $128.90M | +16860.39% |
| WHWK | Whitehawk Therapeutics Inc | $127.23M | +16640.92% |
| RPTX | Repare Therapeutics Inc | $126.75M | +16577.24% |
| RZLT | Rezolute Inc | $125.46M | +16407.76% |
| TENX | Tenax Therapeutics Inc | $123.18M | +16107.63% |
| GBIO | Generation Bio Company | $121.90M | +15938.95% |
| SRZN | Surrozen Inc | $120.71M | +15782.76% |
| PRLD | Prelude Therapeutics Inc | $119.64M | +15642.37% |
| MCRB | Seres Therapeutics Inc | $117.62M | +15376.05% |
| YMAB | Y-Mabs Therapeutics Inc | $117.21M | +15322.50% |
| SGMT | Sagimet Biosciences Inc - Class A | $116.48M | +15226.58% |
| AVTX | Avalo Therapeutics Inc | $116.46M | +15223.42% |
| SLN | Silence Therapeutics Plc | $115.12M | +15047.76% |
| NAGE | Niagen Bioscience Inc | $114.33M | +14943.29% |
| SLS | SELLAS Life Sciences Group Inc | $114.18M | +14923.29% |
| HUMA | Humacyte Inc | $110.56M | +14446.97% |
| EPIX | Essa Pharma Inc | $110.50M | +14439.75% |
| KLRS | Kalaris Therapeutics Inc | $109.81M | +14348.03% |
| FGEN | FibroGen Inc | $109.63M | +14324.87% |
| LCTX | Lineage Cell Therapeutics Inc | $109.53M | +14312.24% |
| SAVA | Cassava Sciences Inc. | $108.37M | +14158.82% |
| ACRV | Acrivon Therapeutics Inc | $107.83M | +14088.42% |
| CELU | Celularity Inc - Class A | $107.33M | +14022.24% |
| DRTS | Alpha Tau Medical Ltd | $105.65M | +13801.58% |
| CAMP | CAMP4 Therapeutics Corp | $105.46M | +13775.92% |
| PLX | Protalix BioTherapeutics Inc | $102.34M | +13365.26% |
| STTK | Shattuck Labs Inc | $102.12M | +13336.97% |
| OBIO | Orchestra BioMed Holdings Inc | $100.66M | +13144.47% |
| VTVT | vTv Therapeutics Inc - Class A | $99.49M | +12991.32% |
| GUTS | Fractyl Health Inc | $99.39M | +12976.97% |
| PRQR | ProQR Therapeutics N.V | $99.14M | +12944.38% |
| AARD | Aardvark Therapeutics Inc | $98.59M | +12872.37% |
| PMVP | PMV Pharmaceuticals Inc | $96.56M | +12605.53% |
| IMMX | Immix Biopharma Inc | $95.82M | +12507.38% |
| DWTX | Virios Therapeutics Inc | $95.21M | +12427.35% |
| NERV | Minerva Neurosciences Inc | $94.03M | +12271.99% |
| BRNS | Barinthus Biotherapeutics Plc. | $92.14M | +12024.08% |
| ANTX | AN2 Therapeutics Inc | $87.49M | +11411.97% |
| MOLN | Molecular Partners AG | $87.40M | +11399.50% |
| EPRX | Eupraxia Pharmaceuticals Inc | $86.15M | +11235.53% |
| IBIO | iBio Inc | $85.83M | +11193.95% |
| FBRX | Forte Biosciences Inc | $82.78M | +10791.97% |
| MDWD | MediWound Ltd | $79.98M | +10423.95% |
| ATYR | Atyr Pharma Inc | $79.65M | +10380.79% |
| ADAG | Adagene Inc | $78.26M | +10197.80% |
| ADVM | Adverum Biotechnologies Inc | $72.40M | +9426.45% |
| FENC | Fennec Pharmaceuticals Inc | $71.82M | +9350.26% |
| ATHA | Athira Pharma Inc | $71.59M | +9319.74% |
| HYPD | Eyenovia Inc | $70.07M | +9119.21% |
| ARMP | Armata Pharmaceuticals Inc | $69.80M | +9084.21% |
| ACOG | Alpha Cognition Inc | $69.25M | +9011.62% |
| GRCE | Acasti Pharma Inc | $68.49M | +8911.58% |
| KZR | Kezar Life Sciences Inc | $68.00M | +8847.24% |
| NBTX | Nanobiotix | $67.76M | +8815.79% |
| PMN | ProMIS Neurosciences Inc | $67.41M | +8769.94% |
| IRD | Ocuphire Pharma Inc | $66.79M | +8687.76% |
| ALDX | Aldeyra Therapeutics Inc | $66.48M | +8647.77% |
| MURA | Mural Oncology plc | $65.76M | +8552.37% |
| VTGN | VistaGen Therapeutics Inc | $65.06M | +8460.00% |
| ALGS | Aligos Therapeutics Inc | $64.56M | +8394.47% |
| UNCY | Unicycive Therapeutics Inc | $64.41M | +8374.47% |
| PYXS | Pyxis Oncology Inc | $64.30M | +8360.53% |
| QTTB | Q32 Bio Inc | $63.67M | +8278.29% |
| EQ | Equillium Inc | $63.08M | +8200.39% |
| IPHA | Innate Pharma | $62.69M | +8148.99% |
| MRSN | Mersana Therapeutics Inc | $62.69M | +8148.16% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $62.12M | +8073.29% |
| HOOK | Hookipa Pharma Inc | $61.26M | +7960.00% |
| CNTB | Connect Biopharma Holdings Ltd | $60.07M | +7803.42% |
| SGMO | Sangamo Therapeutics Inc | $59.97M | +7790.13% |
| KLTO | Klotho Neurosciences Inc Com | $59.74M | +7760.14% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $59.74M | +7760.14% |
| SPRO | Spero Therapeutics Inc | $59.02M | +7665.92% |
| CNTX | Context Therapeutics Inc | $58.86M | +7644.62% |
| HOWL | Werewolf Therapeutics Inc | $58.02M | +7534.47% |
| LITS | Lite Strategy Inc | $57.79M | +7503.82% |
| OCGN | Ocugen Inc | $56.91M | +7387.50% |
| ATHE | Alterity Therapeutics Ltd | $56.86M | +7381.90% |
| KTTA | Pasithea Therapeutics Corp | $56.35M | +7315.12% |
| SPRB | Spruce Biosciences Inc | $56.17M | +7290.26% |
| PMCB | PharmaCyte Biotech Inc | $55.87M | +7251.78% |
| RLYB | Rallybio Corp | $54.47M | +7067.37% |
| COYA | Coya Therapeutics Inc | $53.27M | +6909.36% |
| DMAC | DiaMedica Therapeutics Inc | $53.08M | +6884.21% |
| LVTX | LAVA Therapeutics NV | $51.91M | +6730.92% |
| RANI | Rani Therapeutics Holdings Inc Class A | $51.88M | +6726.18% |
| PHXM | PHAXIAM Therapeutics SA ADR | $51.31M | +6650.92% |
| INO | Inovio Pharmaceuticals Inc | $49.78M | +6449.62% |
| JAGX | Jaguar Health Inc | $49.47M | +6409.47% |
| CRDF | Cardiff Oncology Inc | $49.17M | +6370.00% |
| IFRX | InflaRx N.V. | $48.94M | +6339.58% |
| BOLT | Bolt Biotherapeutics Inc | $48.03M | +6219.34% |
| GRDX | Entero Therapeutics Inc | $47.97M | +6211.27% |
| APRE | Aprea Therapeutics Inc | $47.61M | +6164.79% |
| BMEA | Biomea Fusion Inc | $46.38M | +6003.29% |
| ATNM | Actinium Pharmaceuticals Inc | $45.44M | +5878.68% |
| AKTX | Akari Therapeutics Plc | $45.38M | +5870.53% |
| ICCC | Immucell Corp | $44.11M | +5703.73% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $43.47M | +5619.78% |
| VERU | Veru Inc | $43.08M | +5568.78% |
| MNOV | Medicinova Inc | $42.70M | +5519.06% |
| VANI | Vivani Medical Inc | $42.35M | +5472.76% |
| ACHV | Achieve Life Sciences Inc | $41.79M | +5398.68% |
| BLRX | Bioline Rx Ltd | $40.90M | +5282.15% |
| MREO | Mereo Biopharma Group Plc | $40.61M | +5243.95% |
| IOBT | IO Biotech Inc | $39.96M | +5157.37% |
| VRCA | Verrica Pharmaceuticals Inc | $38.79M | +5003.42% |
| TOVX | Theriva Biologics Inc | $38.25M | +4932.63% |
| SNTI | Senti Biosciences Inc | $38.24M | +4931.71% |
| NXTC | Nextcure Inc | $37.98M | +4896.97% |
| ATOS | Atossa Therapeutics Inc | $37.94M | +4892.50% |
| PASG | Passage Bio Inc | $36.46M | +4697.63% |
| CGTX | Cognition Therapeutics Inc | $36.14M | +4655.26% |
| LYRA | Lyra Therapeutics Inc | $36.11M | +4651.05% |
| MAIA | MAIA Biotechnology Inc | $35.32M | +4547.72% |
| ALLR | Allarity Therapeutics Inc | $34.92M | +4495.13% |
| NEUP | Neuphoria Therapeutics Inc | $34.81M | +4480.16% |
| APLT | Applied Therapeutics Inc | $34.37M | +4422.89% |
| ITRM | Iterum Therapeutics Plc | $32.50M | +4176.71% |
| GNLX | Genelux Corp | $32.37M | +4159.47% |
| GNTA | Genenta Science SpA | $31.89M | +4095.96% |
| CUE | Cue Biopharma Inc | $30.88M | +3962.76% |
| CING | Cingulate Inc | $30.86M | +3960.75% |
| SLGL | Sol-Gel Technologies Ltd | $29.92M | +3836.45% |
| HURA | TuHURA Biosciences Inc | $29.70M | +3808.52% |
| CRIS | Curis Inc | $29.69M | +3806.05% |
| CSBR | Champions Oncology Inc | $28.45M | +3643.03% |
| DARE | Dare Bioscience Inc | $27.83M | +3561.63% |
| NCNA | NuCana plc | $27.55M | +3525.57% |
| HCWB | HCW Biologics Inc | $27.34M | +3497.66% |
| SER | AgeX Therapeutics Inc | $27.30M | +3491.97% |
| QNCX | Quince Therapeutics Inc | $26.62M | +3403.03% |
| INAB | IN8bio Inc | $26.27M | +3355.92% |
| PLUR | Pluri Inc | $26.06M | +3328.55% |
| VYNE | VYNE Therapeutics Inc | $25.87M | +3304.34% |
| INMB | INmune Bio Inc | $25.82M | +3297.11% |
| TVRD | Cara Therapeutics Inc | $25.82M | +3296.97% |
| CASI | CASI Pharmaceuticals Inc | $25.65M | +3275.00% |
| NVCT | Nuvectis Pharma Inc | $25.40M | +3241.84% |
| LPCN | Lipocine Inc | $25.36M | +3236.60% |
| PDSB | PDS Biotechnology Corporation | $24.66M | +3145.13% |
| RNTX | Rein Therapeutics Inc | $24.16M | +3078.68% |
| EVAX | Evaxion Biotech A/S | $23.64M | +3010.79% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $23.56M | +2999.95% |
| MBRX | Moleculin Biotech Inc | $23.36M | +2974.08% |
| HYFT | MindWalk Holdings Corp | $23.17M | +2948.24% |
| CVM | Cel-Sci Corp | $22.89M | +2912.46% |
| ELTX | Elicio Therapeutics Inc | $22.69M | +2885.39% |
| PYPD | Polypid Ltd | $22.31M | +2835.13% |
| OTLK | Outlook Therapeutics Inc | $21.89M | +2780.58% |
| PLRZ | Polyrizon Ltd | $21.44M | +2720.66% |
| KPRX | Kiora Pharmaceuticals Inc | $21.23M | +2693.04% |
| LGVN | Longeveron Inc - Class A | $21.21M | +2690.79% |
| JSPR | Jasper Therapeutics Inc | $21.18M | +2687.37% |
| MENS | Jyong Biotech Ltd | $20.78M | +2633.95% |
| GNPX | Genprex Inc | $20.31M | +2571.88% |
| LPTX | Leap Therapeutics Inc | $20.04M | +2537.11% |
| ATRA | Atara Biotherapeutics Inc | $20.00M | +2531.18% |
| PSTV | Plus Therapeutics Inc | $19.92M | +2520.53% |
| APVO | Aptevo Therapeutics Inc | $19.90M | +2518.68% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $19.79M | +2503.51% |
| ABVC | ABVC BioPharma Inc | $19.73M | +2496.39% |
| SKYE | Skye Bioscience Inc | $19.42M | +2454.83% |
| GANX | Gain Therapeutics Inc | $18.74M | +2365.59% |
| APM | Aptorum Group Ltd - Class A | $18.69M | +2359.39% |
| TTRX | Turn Therapeutics Inc | $18.64M | +2353.18% |
| GLMD | Galmed Pharmaceuticals Ltd | $18.63M | +2350.92% |
| BYSI | BeyondSpring Inc | $18.41M | +2321.84% |
| EVGN | Evogene Ltd | $17.95M | +2261.58% |
| BIVI | BioVie Inc - Class A | $17.51M | +2204.56% |
| MRKR | Marker Therapeutics Inc | $17.43M | +2193.95% |
| PHIO | Phio Pharmaceuticals Corp | $17.41M | +2191.05% |
| IBO | NYSE AMEX LISTED TEST STOCK FOR CTS CQS | $17.09M | +2148.16% |
| MBIO | Mustang Bio Inc | $16.58M | +2081.84% |
| ANVS | Annovis Bio Inc | $16.24M | +2037.33% |
| GALT | Galectin Therapeutics Inc | $15.76M | +1973.55% |
| QNRX | Quoin Pharmaceuticals Ltd | $15.69M | +1964.85% |
| ONCT | Oncternal Therapeutics Inc | $15.60M | +1952.76% |
| ANIX | Anixa Biosciences Inc | $15.23M | +1904.34% |
| IMRN | Immuron Ltd | $15.12M | +1889.81% |
| CRVO | CervoMed Inc | $15.11M | +1888.54% |
| PPCB | Propanc Biopharma Inc | $15.11M | +1888.36% |
| REVB | Revelation Biosciences Inc | $15.04M | +1879.51% |
| CLRB | Cellectar Biosciences Inc | $14.98M | +1870.83% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $14.98M | +1870.42% |
| ELAB | PMGC Holdings Inc | $14.94M | +1865.53% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $14.88M | +1858.49% |
| ONCO | Onconetix Inc | $14.83M | +1851.59% |
| BDRX | Biodexa Pharmaceuticals Plc | $14.82M | +1850.53% |
| SYBX | Synlogic Inc | $14.61M | +1822.50% |
| MTVA | MetaVia Inc | $14.39M | +1793.16% |
| LSTA | Lisata Therapeutics Inc | $14.06M | +1749.87% |
| XCUR | Exicure Inc | $14.04M | +1747.50% |
| RNXT | RenovoRx Inc | $13.96M | +1737.37% |
| CMMB | Chemomab Therapeutics Ltd | $13.81M | +1717.37% |
| YDES | YD Bio Ltd | $13.78M | +1713.08% |
| PTN | Palatin Technologies Inc | $13.23M | +1640.18% |
| ENTX | Entera Bio Ltd | $13.13M | +1627.50% |
| PBM | Psyence Biomedical Ltd | $12.81M | +1585.55% |
| ARTL | Artelo Biosciences Inc | $12.52M | +1547.11% |
| EDSA | Edesa Biotech Inc | $12.38M | +1529.57% |
| KALA | Kala Bio Inc | $12.32M | +1520.79% |
| INTS | Intensity Therapeutics Inc | $12.29M | +1517.24% |
| AZTR | Azitra Inc | $12.13M | +1495.63% |
| NRXP | NRX Pharmaceuticals Inc | $11.90M | +1466.18% |
| ADTX | Aditxt Inc | $11.80M | +1452.58% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $11.64M | +1431.71% |
| SCNI | Scinai Immunotherapeutics Ltd | $11.63M | +1429.74% |
| NCEL | NLS Pharmaceutics Ltd | $11.45M | +1405.92% |
| GRI | GRI Bio Inc | $11.34M | +1391.97% |
| ICU | SeaStar Medical Holding Corp | $11.26M | +1381.97% |
| CMND | Clearmind Medicine Inc | $11.14M | +1365.35% |
| LIXT | Lixte Biotechnology Holdings Inc | $10.87M | +1329.64% |
| CLGN | CollPlant Biotechnologies Ltd New | $10.79M | +1319.08% |
| TPST | Tempest Therapeutics Inc | $10.75M | +1314.21% |
| TRAW | Traws Pharma Inc | $10.62M | +1296.97% |
| ERNA | Ernexa Therapeutics Inc | $10.54M | +1287.24% |
| INKT | MiNK Therapeutics Inc | $10.38M | +1265.39% |
| NNVC | NanoViricides Inc | $10.22M | +1244.61% |
| HIND | ReShape Lifesciences Inc | $10.19M | +1240.19% |
| LNAI | Lunai Bioworks Inc | $9.86M | +1197.44% |
| CLDI | Calidi Biotherapeutics Inc | $9.59M | +1161.97% |
| CDIO | Cardio Diagnostics Holdings Inc | $9.56M | +1157.81% |
| ACXP | Acurx Pharmaceuticals Inc | $9.54M | +1155.26% |
| CANF | Can-Fite Biopharma Ltd | $9.51M | +1151.84% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $9.42M | +1139.74% |
| IGC | IGC Pharma Inc | $9.19M | +1108.55% |
| ACTU | Actuate Therapeutics Inc | $8.91M | +1072.54% |
| NRXS | Neuraxis Inc | $8.75M | +1050.75% |
| AEON | AEON Biopharma Inc - Class A | $8.63M | +1035.53% |
| CALC | CalciMedica Inc | $8.61M | +1032.76% |
| BCAB | BioAtla Inc | $8.57M | +1027.11% |
| CDT | CDT Equity Inc | $8.55M | +1025.26% |
| CYCN | Cyclerion Therapeutics Inc | $8.51M | +1019.08% |
| SLRX | Decoy Therapeutics Inc | $8.42M | +1008.33% |
| CURX | Curanex Pharmaceuticals Inc | $8.41M | +1006.75% |
| ONCY | Oncolytics Biotech Inc | $8.16M | +973.82% |
| IMNN | Imunon Inc | $8.02M | +955.09% |
| GDTC | CytoMed Therapeutics Ltd | $7.98M | +950.65% |
| XBIO | Xenetic Biosciences Inc | $7.91M | +940.66% |
| DYAI | Dyadic International Inc DE | $7.81M | +927.58% |
| BGMS | Bio Green Med Solution Inc | $7.56M | +895.26% |
| NTRB | Nutriband Inc | $7.55M | +893.15% |
| OGEN | Oragenics Inc | $7.49M | +885.48% |
| DRMA | Dermata Therapeutics Inc | $7.47M | +882.32% |
| COCP | Cocrystal Pharma Inc | $7.43M | +877.11% |
| TELO | Telomir Pharmaceuticals Inc | $7.34M | +865.97% |
| OSTX | OS Therapies Inc | $7.30M | +860.43% |
| LTRN | Lantern Pharma Inc | $7.22M | +850.40% |
| ASBP | Aspire Biopharma Holdings Inc | $7.12M | +836.47% |
| SILO | SILO Pharma Inc | $7.02M | +823.44% |
| VIVS | VivoSim Labs Inc | $6.96M | +815.79% |
| SNGX | Soligenix Inc | $6.92M | +810.87% |
| INDP | Indaptus Therapeutics Inc | $6.84M | +800.01% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $6.76M | +789.91% |
| GTBP | GT Biopharma Inc | $6.76M | +789.34% |
| APLM | Apollomics Inc - Class A | $6.71M | +783.42% |
| LEXX | Lexaria Bioscience Corp | $6.49M | +753.59% |
| CELZ | Creative Medical Technology Holdings Inc | $6.44M | +747.44% |
| ADXN | Addex Therapeutics Ltd | $6.37M | +737.68% |
| FBLG | FibroBiologics Inc | $5.94M | +681.32% |
| MTNB | Matinas Biopharma Holdings Inc | $5.87M | +672.89% |
| AIM | AIM ImmunoTech Inc. | $5.78M | +660.79% |
| KAPA | Kairos Pharma Ltd | $5.74M | +655.79% |
| VRAX | Virax Biolabs Group Ltd - Class A | $5.72M | +651.98% |
| HOTH | Hoth Therapeutics Inc | $5.59M | +636.05% |
| ENVB | Enveric Biosciences Inc | $5.52M | +626.51% |
| ADIL | Adial Pharmaceuticals Inc | $5.23M | +587.81% |
| BBLG | Bone Biologics Corp | $4.98M | +555.17% |
| TVGN | Tevogen Bio Holdings Inc | $4.92M | +547.50% |
| CNSP | Cns Pharmaceuticals Inc | $4.65M | +512.26% |
| OKYO | OKYO Pharma Ltd - New | $4.64M | +511.03% |
| BRTX | BioRestorative Therapies Inc | $4.64M | +510.56% |
| SLXN | Silexion Therapeutics Corp | $4.60M | +505.53% |
| PCSA | Processa Pharmaceuticals Inc | $4.52M | +494.86% |
| PULM | Pulmatrix Inc | $4.50M | +491.58% |
| PTIX | Protagenic Therapeutics Inc | $4.43M | +483.04% |
| ALZN | Alzamend Neuro Inc | $4.04M | +431.82% |
| EXOZ | Invizyne Technologies Inc | $4.02M | +428.79% |
| JUNS | Jupiter Neurosciences Inc | $3.95M | +419.55% |
| GLSI | Greenwich LifeSciences Inc | $3.81M | +400.92% |
| ESLA | Estrella Immunopharma Inc | $3.66M | +381.21% |
| NTHI | NeOnc Technologies Holdings Inc | $3.33M | +338.18% |
| PHGE | BiomX Inc | $3.25M | +327.76% |
| TTNP | Titan Pharmaceuticals Inc (de) | $3.05M | +301.45% |
| GOVX | Geovax Labs Inc | $2.98M | +292.43% |
| CVKD | Cadrenal Therapeutics Inc | $2.86M | +276.59% |
| LIMN | Liminatus Pharma Inc | $2.79M | +267.14% |
| ENSC | Ensysce Biosciences Inc | $2.17M | +185.24% |
| XRTX | XORTX Therapeutics Inc | $2.15M | +183.14% |
| TCRT | Alaunos Therapeutics Inc | $1.88M | +147.76% |
| BCDA | BioCardia Inc | $1.71M | +125.26% |
| ABP | Abpro Holdings, Inc Common Stock | $1.06M | +39.87% |
| NRSN | NeuroSense Therapeutics Ltd | $1.03M | +35.26% |
| ZVSA | ZyVersa Therapeutics Inc | $742223.00 | -2.34% |